CIR1
Basic information
Region (hg38): 2:174348022-174395712
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CIR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 33 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 0 | 0 |
Variants in CIR1
This is a list of pathogenic ClinVar variants found in the CIR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-174348549-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
2-174348619-G-C | not specified | Uncertain significance (Dec 13, 2023) | ||
2-174348624-C-T | not specified • EBV-positive nodal T- and NK-cell lymphoma | Uncertain significance (Oct 10, 2023) | ||
2-174348633-C-T | not specified | Uncertain significance (Apr 08, 2024) | ||
2-174348634-G-A | not specified | Uncertain significance (Aug 01, 2024) | ||
2-174348678-C-T | not specified | Uncertain significance (Dec 04, 2024) | ||
2-174348687-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
2-174348688-G-A | not specified | Uncertain significance (Apr 12, 2022) | ||
2-174348742-C-T | not specified | Uncertain significance (May 10, 2023) | ||
2-174348763-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
2-174348772-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
2-174348796-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
2-174348816-C-G | not specified | Uncertain significance (May 31, 2023) | ||
2-174348840-C-T | not specified | Uncertain significance (Nov 08, 2024) | ||
2-174348859-T-C | not specified | Uncertain significance (Sep 25, 2023) | ||
2-174348898-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
2-174348919-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
2-174348934-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
2-174348986-T-A | not specified | Uncertain significance (Jun 17, 2024) | ||
2-174349010-A-T | not specified | Uncertain significance (Aug 02, 2021) | ||
2-174349085-A-C | not specified | Uncertain significance (May 26, 2023) | ||
2-174349153-T-C | not specified | Uncertain significance (Sep 20, 2024) | ||
2-174350726-C-A | not specified | Uncertain significance (Dec 06, 2021) | ||
2-174350729-T-A | not specified | Uncertain significance (Mar 22, 2023) | ||
2-174350743-C-G | not specified | Uncertain significance (Jun 11, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CIR1 | protein_coding | protein_coding | ENST00000342016 | 10 | 47694 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.31e-8 | 0.857 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.04 | 179 | 223 | 0.804 | 0.0000113 | 3007 |
Missense in Polyphen | 27 | 28.834 | 0.93638 | 426 | ||
Synonymous | -0.909 | 88 | 77.8 | 1.13 | 0.00000408 | 738 |
Loss of Function | 1.60 | 15 | 23.3 | 0.643 | 0.00000134 | 301 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000531 | 0.000530 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000989 | 0.0000924 |
European (Non-Finnish) | 0.000279 | 0.000273 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000987 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May modulate splice site selection during alternative splicing of pre-mRNAs (By similarity). Regulates transcription and acts as corepressor for RBPJ. Recruits RBPJ to the Sin3-histone deacetylase complex (HDAC). Required for RBPJ-mediated repression of transcription. {ECO:0000250, ECO:0000269|PubMed:19409814, ECO:0000269|PubMed:9874765}.;
- Pathway
- Notch signaling pathway - Homo sapiens (human);Notch Signaling Pathway;Notch
(Consensus)
Intolerance Scores
- loftool
- 0.255
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.89
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.611
- ghis
- 0.496
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.814
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cir1
- Phenotype
- embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; skeleton phenotype; renal/urinary system phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- mRNA processing;RNA splicing;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;cytoplasm;centrosome;nuclear speck;protein-containing complex
- Molecular function
- DNA-binding transcription factor activity;transcription corepressor activity;protein binding;protein kinase binding;protein-containing complex binding